A midsize pharma company launched an oncology therapy with a novel drug delivery mechanism to reduce tumor toxicity. As the company’s market access team had secured favorable formulary placement with most major payers, it expected a steady uptake curve. However, adoption rates remained low. The manufacturer needed a better understanding of how IDNs might be […]

Pharma commercial leaders in TAs with high clinical need often tell reps to focus on efficacy and leave the coverage conversations for later. New MMIT research reveals that this approach is costing manufacturers valuable script lift. In this research paper, learn why providers are much more likely to adopt a new therapy when they understand […]

INFOGRAPHIC Unmatched Payer Market Clarity Understanding the complexity of the payer market requires more than just enrollment data.  MMIT’s Landscape iQ solution provides a clear, detailed view of how the market is changing and which entities are driving access — connecting lives, plans, organizations, geographies, relationships, and historical context in one interactive tool. What you’ll […]

A year after launching a new oncology therapy, one manufacturer wanted to map the patient journey to identify access barriers. To build a longitudinal patient dataset, the company purchased both open and closed claims data from multiple vendors, along with transactional records. This patient data was then de-identified and linked via a third-party token engine. […]

In this use case, learn how MMIT helped one pharma company develop a custom communication about its infusion therapy’s new NDC and J-codes.

This infographic breaks down what truly sets us apart. MMIT moves beyond reporting data to help pharma teams understand what’s happening, why it’s happening, and how it impacts patients.

This infographic breaks down what truly sets us apart. MMIT moves beyond reporting data to help pharma teams understand what’s happening, why it’s happening, and how it impacts patients.

In this use case, learn how the company partnered with MMIT to better understand payers’ POV. The company used these key insights to refine its brand messaging and improve coverage.

In this use case, find out how MMIT Analytics and Searchlight helped one manufacturer get detailed payer landscape information for its products across different geographic regions.

In this ebook, explore six real-world examples of how leading companies are using ML and NLP to find hidden patient populations and better support those who need treatment most.

In this use case, find out how MMIT, using NorstellaLinQ, helped one manufacturer improve disease-state education and guide more effective account-level targeting by isolating specific patient cohorts with structured and unstructured EMR data.

This webinar explores how pharmaceutical companies can reduce market access risk during the critical pre-launch period leading up to FDA approval. Speakers discuss the importance of accurate uptake forecasting, payer-aligned value propositions, pricing and contracting strategy, payer prioritization, and proactive mitigation planning to avoid launch disruptions and lost market share. The session also highlights how […]